Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06707610 |
| Title | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Antitumor Activity of ALK202 in Participants with Advanced Solid Tumors |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Shanghai Allink Biotherapeutics Co., Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| D&H Cancer Research Center Llc | RECRUITING | Margate | Florida | 33063 | United States | Details |
| Next Oncology | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |
| Scientia Clinical Research Ltd | RECRUITING | Randwick | New South Wales | 2031 | Australia | Details |
| Macquarie University | RECRUITING | Sydney | New South Wales | 2109 | Australia | Details |